These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 30291840)
1. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014. Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840 [TBL] [Abstract][Full Text] [Related]
2. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015. Yu O; Schulze-Rath R; Grafton J; Hansen K; Scholes D; Reed SD Am J Obstet Gynecol; 2020 Jul; 223(1):94.e1-94.e10. PubMed ID: 31954156 [TBL] [Abstract][Full Text] [Related]
3. Incidence, prevalence, and trends in endometriosis diagnosis: a United States population-based study from 2006 to 2015. Christ JP; Yu O; Schulze-Rath R; Grafton J; Hansen K; Reed SD Am J Obstet Gynecol; 2021 Nov; 225(5):500.e1-500.e9. PubMed ID: 34147493 [TBL] [Abstract][Full Text] [Related]
4. Minimally invasive myomectomy: practice trends and differences between Black and non-Black women within a large integrated healthcare system. Zaritsky E; Le A; Tucker LY; Ojo A; Weintraub MR; Raine-Bennett T Am J Obstet Gynecol; 2022 Jun; 226(6):826.e1-826.e11. PubMed ID: 35101407 [TBL] [Abstract][Full Text] [Related]
5. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Wise LA; Palmer JR; Stewart EA; Rosenberg L Obstet Gynecol; 2005 Mar; 105(3):563-8. PubMed ID: 15738025 [TBL] [Abstract][Full Text] [Related]
6. Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019. Yu O; Christ JP; Schulze-Rath R; Covey J; Kelley A; Grafton J; Cronkite D; Holden E; Hilpert J; Sacher F; Micks E; Reed SD Am J Obstet Gynecol; 2023 Jul; 229(1):39.e1-39.e12. PubMed ID: 37061077 [TBL] [Abstract][Full Text] [Related]
7. Growth of uterine leiomyomata among premenopausal black and white women. Peddada SD; Laughlin SK; Miner K; Guyon JP; Haneke K; Vahdat HL; Semelka RC; Kowalik A; Armao D; Davis B; Baird DD Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19887-92. PubMed ID: 19047643 [TBL] [Abstract][Full Text] [Related]
8. Associations between Race/Ethnicity, Uterine Fibroids, and Minimally Invasive Hysterectomy in the VA Healthcare System. Callegari LS; Katon JG; Gray KE; Doll K; Pauk S; Lynch KE; Uchendu US; Zephyrin L; Gardella C Womens Health Issues; 2019; 29(1):48-55. PubMed ID: 30293778 [TBL] [Abstract][Full Text] [Related]
9. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records. Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754 [TBL] [Abstract][Full Text] [Related]
10. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans. Baird DD; Patchel SA; Saldana TM; Umbach DM; Cooper T; Wegienka G; Harmon QE Am J Obstet Gynecol; 2020 Sep; 223(3):402.e1-402.e18. PubMed ID: 32105679 [TBL] [Abstract][Full Text] [Related]
11. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures. Becker ER J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228 [TBL] [Abstract][Full Text] [Related]
12. Racial Disparities in Uterine Fibroid Treatment Among Veterans Using VA Health Care. Katon JG; Bossick A; Carey C; Christy A; Doll K; Gatsby E; Gray KE; Lynch KE; Moy E; Owens S; Washington DL; Callegari LS Womens Health Issues; 2023; 33(4):405-413. PubMed ID: 37105835 [TBL] [Abstract][Full Text] [Related]
13. Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study. Borahay MA; Fang X; Baillargeon JG; Kilic GS; Boehning DF; Kuo YF Am J Obstet Gynecol; 2016 Dec; 215(6):750.e1-750.e8. PubMed ID: 27371355 [TBL] [Abstract][Full Text] [Related]
14. Inpatient surgical treatment patterns for patients with uterine fibroids in the United States, 1998-2002. Becker ER; Spalding J; DuChane J; Horowitz IR J Natl Med Assoc; 2005 Oct; 97(10):1336-42. PubMed ID: 16353655 [TBL] [Abstract][Full Text] [Related]
15. Uterine fibroids, active component females, U.S. Armed Forces, 2001-2010. Armed Forces Health Surveillance Center (AFHSC) MSMR; 2011 Dec; 18(12):10-3. PubMed ID: 22229335 [TBL] [Abstract][Full Text] [Related]
16. Incidence and health care burden of uterine fibroids among female service members in the active component of the U.S. Armed Forces, 2011-2022. Nieh C; Mabila SL MSMR; 2024 Feb; 31(2):9-15. PubMed ID: 38466970 [TBL] [Abstract][Full Text] [Related]
17. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Baird DD; Dunson DB; Hill MC; Cousins D; Schectman JM Am J Obstet Gynecol; 2003 Jan; 188(1):100-7. PubMed ID: 12548202 [TBL] [Abstract][Full Text] [Related]
18. Herpes Simplex Virus Type 2 Seroprevalence and Incidence and Growth of Ultrasound-Diagnosed Uterine Fibroids in a Large Population of Young African-American Women. Moore KR; Harmon QE; Baird DD Am J Epidemiol; 2021 Oct; 190(10):2158-2162. PubMed ID: 34038935 [TBL] [Abstract][Full Text] [Related]